Search results
Merck Wins US Approval for Pneumonia Vaccine to Rival Pfizer’s
Bloomberg· 7 days agoMerck & Co. won US approval for a pneumococcal vaccine that threatens to unseat one of Pfizer Inc.’s...
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 7 days agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 6 days agoThis includes the eight unique serotypes, 15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B compared to other...
IPG Health lays off 5% of US staff, primarily blaming Pfizer loss
Ad Age· 5 days agoThe “reductions occurred across our U.S. agencies” and did not only affect employees who worked on the Pfizer account, IPG Health told Ad Age in a statement. “The
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 4 days agoStocks of pharma companies, particularly large ones, make excellent defensive investments in an...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 7 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed in state court in ...
Sarepta’s Elevidys secures US label expansion for DMD
Pharmaceutical Technology via Yahoo Finance· 3 days agoJust a week after Pfizer revealed a Phase III trial failure for its mini-dystrophin gene therapy for...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 6 days agoOne, dubbed Pneumovax 23, is for adults at least 50 years of age and children older than two who are...
Alnylam's drug cuts risk of death, heart issues in key study, shares jump
Reuters via Yahoo News· 4 hours ago(Reuters) -Alnylam Pharmaceuticals said on Monday its drug vutrisiran helped reduce the number of deaths and cardiovascular events in a study involving patients with a rare heart disease, sending ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...